Response to FDA draft guidance on pediatric IBD drug approval trials: A consensus statement from the IBD Porto Group
Year: 2024
Type: article
DOI: 10.1002/jpn3.12395
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W4404545587
